Genenta Science S.p.A.
NASDAQ:GNTA
3.95 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.042 | 0.006 | 0.005 | 0.002 | 0 |
| Gross Profit
| -0.042 | -0.006 | -0.005 | -0.002 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 6.342 | 5.339 | 3.391 | 4.688 | 3.703 |
| General & Administrative Expenses
| 5.259 | 5.705 | 2.297 | 0.902 | 0.922 |
| Selling & Marketing Expenses
| 5.104 | 0 | 0 | 0 | 0 |
| SG&A
| 5.109 | 5.705 | 2.297 | 0.902 | 0.922 |
| Other Expenses
| 0 | 0.243 | -0.15 | 0.006 | 0.036 |
| Operating Expenses
| 11.451 | 11.044 | 5.537 | 5.59 | 4.625 |
| Operating Income
| -11.492 | -11.044 | -5.687 | -5.59 | -4.625 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.086 | 2.566 | 0.158 | -0.002 | 0.027 |
| Income Before Tax
| -11.407 | -8.478 | -5.529 | -5.592 | -4.598 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -4.853 | 0.031 | 0.014 | 0.01 |
| Net Income
| -11.407 | -3.625 | -5.561 | -5.606 | -4.607 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.63 | -0.2 | -0.31 | -0.31 | -0.25 |
| EPS Diluted
| -0.63 | -0.2 | -0.31 | -0.31 | -0.25 |
| EBITDA
| -11.451 | -13.325 | -5.513 | -5.582 | -4.588 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 |